PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapsjspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS J. 2005 March; 7(1): E156–E194.
Published online 2005 August 18. doi:  10.1208/aapsj070117
PMCID: PMC2607485
NIHMSID: NIHMS75092

Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series

Abstract

A data set was generated to examine global changes in gene expression in rat liver over time in response to a single bolus dose of methylprednisolone. Four control animals and 43 drug-treated animals were humanely killed at 16 different time points following drug administration. Total RNA preparation from the livers of these animals were hybridized to 47 individual Affymetrix RU34A gene chips, generating data for 8799 different probe sets for each chip. Data mining techniques that are applicable to gene array time series data sets in order to identify drug-regulated changes in gene expression were applied to this data set. A series of 4 sequentially applied filters were developed that were designed to eliminate probe sets that were not expressed in the tissue, were not regulated by the drug treatment, or did not meet defined quality control standards. These filters eliminated 7287 probe sets of the 8799 total (82%) from further consideration. Application of judiciously chosen filters is an effective tool for data mining of time series data sets. The remaining data can then be further analyzed by clustering and mathematical modeling techniques.

Full Text

The Full Text of this article is available as a PDF (6.3M).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Bialis M, Routledge P. Adverse effects of corticosteroids. Adverse Drug React Toxicol Rev. 1998;17:227–235. [PubMed]
2. Frauman A. An overview of the adverse reactions to adrenal corticosteroids. Adverse Drug React Toxicol Rev. 1996;15:203–206. [PubMed]
3. Reynolds RM, Walker BR. Human insulin resistance: the role of glucocorticoids. Diabetes Obes Metab. 2003;5:5–12. doi: 10.1046/j.1463-1326.2003.00221.x. [PubMed] [Cross Ref]
4. Eisenstein A. Effects of adrenal cortical hormones on carbohydrate, protein, and fat metabolism. Am J Clin Nutr. 1973;26:113–120. [PubMed]
5. Jin JY, Almon RR, DuBois DC, Jusko WJ. Modeling of corticosteroid pharmacogenomics in rat liver using gene microarrays. J Pharmacol Exp Ther. 2003;307:93–109. doi: 10.1124/jpet.103.053256. [PubMed] [Cross Ref]
6. Friedman N, Kaminski N. Statistical Methods for Analyzing Gene Expression Data for Cancer Research. Berlin, Germany: Springer-Verlag; 2002. pp. 109–131.
7. Kaminski N. Microarray analysis of idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2003;29:S32–S36. [PubMed]
8. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8:500–508. doi: 10.1038/nm0502-500. [PubMed] [Cross Ref]
9. Sun YN, DuBois DC, Almon RR, Juskø WJ. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm. 1998;26:289–317. doi: 10.1023/A:1020746822634. [PubMed] [Cross Ref]
10. Sun YN, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J Pharmacokinet Biopharm. 1998;26:619–648. doi: 10.1023/A:1020746822634. [PubMed] [Cross Ref]
11. Sun YN, McKay LI, DuBois DC, Jusko WJ, Almon RR. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. J Pharmacol Exp Ther. 1999;288:720–728. [PubMed]
12. Almon RR, DuBois DC, Brandenburg EH, et al. Pharmacodynamics and pharmacogenomics of diverse receptor-mediated effects of methylprednisolone in rats using microarray analysis. J Pharmacokinet Pharmacodyn. 2002;29:103–129. doi: 10.1023/A:1019762323576. [PubMed] [Cross Ref]
13. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998;95:1486–14868. doi: 10.1073/pnas.95.25.14863. [Cross Ref]
14. Takiguchi M, Mori M. Transcriptional regulation of genes for ornithine cycle enzymes. Biochem J. 1985;312:649–659. [PubMed]
15. McKay LI, DuBois DC, Sun YN, Almon RR, Jusko WJ. Corticosteroid effects in skeletal muscle: gene induction/receptor autoregulation. Muscle Nerve. 1997;20:1318–1320. doi: 10.1002/(SICI)1097-4598(199710)20:10<1318::AID-MUS17>3.0.CO;2-Z. [PubMed] [Cross Ref]
16. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats. J Pharmacokinet Pharmacodyn. 2002;29:1–24. doi: 10.1023/A:1015765201129. [PubMed] [Cross Ref]
17. Ramakrishnan R, DuBois DC, Almon RR, Pyszczynski NA, Jusko WJ. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. J Pharmacol Exp Ther. 2002;300:245–256. doi: 10.1124/jpet.300.1.245. [PubMed] [Cross Ref]
18. Almon RR, Chen J, Snyder G, DuBois DC, Jusko WJ, Hoffman EP. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR) Pharmacogenomics. 2003;4:791–799. doi: 10.1517/phgs.4.6.791.22816. [PubMed] [Cross Ref]

Articles from The AAPS Journal are provided here courtesy of American Association of Pharmaceutical Scientists